Acceleron Pharma Inc. 5,348,838 Shares(1) Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • January 17th, 2019 • Acceleron Pharma Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 17th, 2019 Company Industry JurisdictionAcceleron Pharma Inc., a corporation organized under the laws of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, 5,348,838 shares of common stock, $0.001 par value (“Common Stock”), of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to 802,325 additional shares of Common Stock (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires. Certain terms used he
Acceleron Pharma Inc. 5,405,406 Shares(1) Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • September 25th, 2017 • Acceleron Pharma Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 25th, 2017 Company Industry JurisdictionAcceleron Pharma Inc., a corporation organized under the laws of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, 5,405,406 shares of common stock, $0.001 par value (“Common Stock”), of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to 810,810 additional shares of Common Stock (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires. Certain terms used he
NATIONAL RETAIL PROPERTIES, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • September 12th, 2017 • National Retail Properties, Inc. • Real estate investment trusts • New York
Contract Type FiledSeptember 12th, 2017 Company Industry JurisdictionNational Retail Properties, Inc., a Maryland corporation (the “Company”), proposes to issue and sell to the several Underwriters named on Schedule I hereto (the “Underwriters”), for whom you are acting as Representatives (the “Representatives”), an aggregate principal amount of $400,000,000 3.50% Notes due 2027 (the “Securities”), to be issued under an indenture (as the same has been and may be amended and supplemented, the “Indenture”) dated as of March 25, 1998, as amended and supplemented by a Sixteenth Supplemental Indenture (the “Sixteenth Supplemental Indenture”) to be dated as of September 14, 2017, between the Company and U.S. Bank National Association, as successor trustee (the “Trustee”). The respective amounts of the Securities to be so purchased by the several Underwriters are set forth opposite their names in Schedule I hereto.
Civeo Corporation 20,000,000 Common Shares Underwriting AgreementUnderwriting Agreement • February 7th, 2017 • Civeo Corp • Hotels, rooming houses, camps & other lodging places • New York
Contract Type FiledFebruary 7th, 2017 Company Industry JurisdictionCiveo Corporation, a British Columbia, Canada limited company (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representative”) are acting as representative, 20,000,000 common shares, without par value (“Common Shares”), of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to 3,000,000 additional Common Shares (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representative as used herein shall mean you, as Underwriter, and the terms Representative and Underwriter shall mean either the singular or plural as the context requires. Certain terms used herein are defined in Section 20
Caesars Entertainment Corporation 7,000,000 Shares Common Stock ($0.01 par value) Underwriting AgreementUnderwriting Agreement • April 2nd, 2014 • CAESARS ENTERTAINMENT Corp • Hotels & motels • New York
Contract Type FiledApril 2nd, 2014 Company Industry JurisdictionCaesars Entertainment Corporation, a corporation organized under the laws of Delaware (the “Company”), proposes to sell to you (the “Underwriter”), 7,000,000 shares of common stock, $0.01 par value (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriter an option to purchase up to 1,050,000 additional shares of Common Stock (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). Any reference herein to the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form S-3, which were filed under the Exchange Act on or before the Effective Date of the Registration Statement or the issue date of the Base Prospectus, any Preliminary Pr
Caesars Entertainment Corporation 10,000,000 Shares Common Stock ($0.01 par value) Underwriting AgreementUnderwriting Agreement • October 1st, 2013 • CAESARS ENTERTAINMENT Corp • Hotels & motels • New York
Contract Type FiledOctober 1st, 2013 Company Industry JurisdictionCaesars Entertainment Corporation, a corporation organized under the laws of Delaware (the “Company”), proposes to sell to you (the “Underwriter”), 10,000,000 shares of common stock, $0.01 par value (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriter an option to purchase up to 1,500,000 additional shares of Common Stock (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). Any reference herein to the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form S-3, which were filed under the Exchange Act on or before the Effective Date of the Registration Statement or the issue date of the Base Prospectus, any Preliminary P
Underwriting AgreementUnderwriting Agreement • October 25th, 2012 • Singulex Inc • Services-medical laboratories • New York
Contract Type FiledOctober 25th, 2012 Company Industry JurisdictionSingulex, Inc., a corporation organized under the laws of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, [ ] shares of common stock, $0.001 par value (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to [ ] additional shares of Common Stock to cover over-allotments, if any (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires. Certai
Underwriting AgreementUnderwriting Agreement • April 10th, 2012 • Digital Cinema Destinations Corp. • Services-motion picture theaters • New York
Contract Type FiledApril 10th, 2012 Company Industry Jurisdiction
Underwriting AgreementUnderwriting Agreement • March 30th, 2012 • Digital Cinema Destinations Corp. • Services-motion picture theaters • New York
Contract Type FiledMarch 30th, 2012 Company Industry Jurisdiction
Underwriting AgreementUnderwriting Agreement • February 15th, 2012 • Digital Cinema Destinations Corp. • Services-motion picture theaters • New York
Contract Type FiledFebruary 15th, 2012 Company Industry Jurisdiction
GAZIT-GLOBE LTD. Ordinary Shares (Par Value NIS 1.00 Per Share) UNDERWRITING AGREEMENTUnderwriting Agreement • December 6th, 2011 • Gazit-Globe LTD • Real estate • New York
Contract Type FiledDecember 6th, 2011 Company Industry JurisdictionCITIGROUP GLOBAL MARKETS INC. DEUTSCHE BANK SECURITIES INC. As Representatives of the several Underwriters listed in Schedule I hereto
Comverge, Inc. 2,400,000 Shares1 Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • November 19th, 2009 • Comverge, Inc. • Auto controls for regulating residential & comml environments • New York
Contract Type FiledNovember 19th, 2009 Company Industry JurisdictionComverge, Inc., a corporation organized under the laws of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, 2,400,000 shares of common stock, $0.001 par value (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to 360,000 additional shares of Common Stock to cover over-allotments, if any (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requir
Amtech Systems, Inc. 2,000,000 Shares * Common Stock ($0.01 par value) Underwriting AgreementUnderwriting Agreement • November 7th, 2007 • Amtech Systems Inc • Special industry machinery, nec • New York
Contract Type FiledNovember 7th, 2007 Company Industry JurisdictionCollins Stewart LLC Oppenheimer & Co. Inc. Broadpoint Capital, Inc. As Representatives of the several Underwriters, c/o Collins Stewart LLC 350 Madison Avenue New York, New York 10017
Rosetta Genomics Ltd. 3,750,000 Ordinary Shares* Underwriting AgreementUnderwriting Agreement • January 23rd, 2007 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 23rd, 2007 Company Industry Jurisdiction
Spansion Inc. 35,000,000 Sharesa/ Class A Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • November 3rd, 2006 • Spansion Inc. • Semiconductors & related devices • New York
Contract Type FiledNovember 3rd, 2006 Company Industry JurisdictionAMD Investments, Inc., a corporation incorporated under the laws of Delaware (“AMDI”), and Fujitsu Limited, a corporation incorporated under the laws of Japan (“Fujitsu”, and together with AMDI, the “Selling Stockholders” and each a “Selling Stockholder”), propose to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, 35,000,000 shares of Class A Common Stock, par value $0.001 per share (“Common Stock”) of Spansion Inc., a corporation incorporated under the laws of Delaware (the “Company”), (said shares hereinafter called (the “Underwritten Securities”). The number of Underwritten Securities sold by each Selling Stockholder shall be as set forth on Schedule II hereto. The Company proposes to grant to the Underwriters an option to purchase up to 5,250,000 newly issued shares of Common Stock to cover over-allotments, if any (the “Option Securities”; the Option Securities, together with the U
Rosetta Genomics Ltd. 3,000,000 Ordinary Shares* Underwriting AgreementUnderwriting Agreement • September 21st, 2006 • Rosetta Genomics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 21st, 2006 Company Industry Jurisdiction
Northstar Neuroscience, Inc. 6,000,000 Shares 1 Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • May 2nd, 2006 • Northstar Neuroscience, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledMay 2nd, 2006 Company Industry JurisdictionNorthstar Neuroscience, Inc., a corporation organized under the laws of the State of Washington (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, 6,000,000 shares of Common Stock, $0.001 par value per share (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to 900,000 additional shares of Common Stock to cover over-allotments (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular
Copart, Inc. 4,000,000 Shares plus an option to purchase from Copart, Inc., up to 600,000 additional shares to cover over-allotments. Common Stock, no par value Underwriting AgreementUnderwriting Agreement • November 20th, 2001 • Copart Inc • Retail-auto dealers & gasoline stations • New York
Contract Type FiledNovember 20th, 2001 Company Industry JurisdictionSalomon Smith Barney Inc. Credit Suisse First Boston Corporation AG Edwards & Sons, Inc. As Representatives of the several Underwriters, c/o Salomon Smith Barney Inc. 388 Greenwich Street New York, New York 10013